Pixium Vision announces reaching its enrollment target in the European pivotal trial PRIMAvera and implantations planned to be completed by end 2022

Pixium Vision announces reaching its enrollment target in the European pivotal trial PRIMAvera and implantations planned to be completed by end 2022 The target number of 38 patients have

Related Keywords

Germany ,Paris ,France General ,France ,Netherlands ,United Kingdom ,Stanford University ,California ,United States ,Italy ,Moorfields ,Ballymena ,Bonn ,Nordrhein Westfalen ,London ,City Of ,Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,French ,Entreprise Innovante ,Frank Holz ,Guillaume Van Renterghem ,Sophie Baumont ,Institute Of Ocular Microsurgery ,Pixium Vision ,Euronext Growth Paris ,Prima System ,Professor Frank Holz ,Institut De La Vision ,Moorfields Eye Hospital ,Ocular Microsurgery ,Risk Factors ,Year Financial Report ,Pixium ,Vision ,Nnounces ,Teaching ,Enrollment ,Target ,European ,Pivotal ,Trial ,Primavera ,Implantations ,Planned ,Ompleted ,022 ,